IMARC Group, a leading market research company, has recently releases report titled “Joint Reconstruction Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global joint reconstruction devices market size, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Industry Overview of Joint Reconstruction Devices Market
Joint reconstruction devices are specifically designed to restore the movement of joints, provide them with structural support either temporarily or permanently, and assist in reconstructing tissue. They are widely utilized together or separately with one or more implantable medical devices as a replacement in whole or part for hip, shoulder, or knee joints. Presently, joint reconstruction devices are extensively utilized by individuals to treat disorders, such as osteoarthritis (OA), that are caused by their unhealthy dietary patterns. They find wide-ranging applications among hospitals, ambulatory surgical centers (ASCs), orthopedic clinics, etc.
How Big Is the Joint Reconstruction Devices Market?
The global joint reconstruction devices market size reached US$ 26.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.
Global Industry Trends and Drivers:
The expanding geriatric population is primarily driving the joint reconstruction devices market. Additionally, the widespread adoption of 3D printing in creating customized bio models, devices, and implants that are replicas of patient anatomy to plan and simulate complex surgical procedures is further bolstering the market growth. Besides this, the introduction of advanced and emerging technologies, including robotics and augmented reality (AR), that are making joint reconstruction safer, more accurate, and efficient is acting as another significant growth-inducing factor. Moreover, the escalating demand for robotic-assisted surgery as an innovative method for hip and knee arthroplasty, which offers real-time information regarding soft tissue tensioning and balance, enhanced component positioning, restoration of hip length and offset, etc., is positively influencing the global market. Apart from this, the rising prevalence of accidental or sports-related injuries that cause broken bones and dislocations is also stimulating the market growth. Furthermore, the growing number of individuals requiring tibiotalar arthrodesis (TTA) and total ankle replacement (TAR) for the surgical management of ankle arthritis is anticipated to fuel the joint reconstruction devices market over the forecasted period.
What Is Included In Market Segmentation?
The report has been segmented the market into following categories:
Breakup by Technique:
- Joint Replacement
- Implants
- Bone Graft
- Osteotomy
- Arthroscopy
- Resurfacing
- Arthrodesis
- Others
Breakup by Joint Type:
- Knee
- Hip
- Shoulder
- Ankle
- Others
Breakup by End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report provides a comprehensive analysis of the industry key players listed below:
Aesculap Inc. (B. Braun Melsungen AG), Conformis Inc., Conmed Corporation, DJO Global Inc. (Enovis Corporation), Exactech Inc., Johnson & Johnson Services Inc, Kyocera Medical Technologies Inc. (Kyocera Corporation), Medacta International SA, Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
